Soluble molecules in lymphoproliferative disorders.
Vinante
F
F
Cattedra di Ematologia, Policlinico Borgo Roma, Verona, Italy.
Morosato
L
L
De Sabata
D
D
Pizzolo
G
G
D015703:Antigens, CD / Q000097:blood*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000097:blood*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000097:blood*; D000951:Antigens, Neoplasm / Q000097:blood*; D016827:CD8 Antigens; D006801:Humans; D017730:Ki-1 Antigen; D008232:Lymphoproliferative Disorders / Q000097:blood*; D011961:Receptors, Fc / Q000097:blood*; D017455:Receptors, IgE; D015375:Receptors, Interleukin-2 / Q000097:blood*; D012995:Solubility
D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D016827:CD8 Antigens; D017730:Ki-1 Antigen; D011961:Receptors, Fc; D017455:Receptors, IgE; D015375:Receptors, Interleukin-2